** Medical equipment maker Thermo Fisher's shares TMO.N rise 2.2% to $444.39 premarket
** TMO posts Q1 adj. profit of $5.15 per share, beating analysts' estimates of $5.10 per share, according to data compiled by LSEG
** Company reports Q1 revenue of $10.36 billion vs estimates of $10.23 billion
** Sales at the company's laboratory products segment, which makes up more than half of its total sales, came in at $5.64 billion vs estimate of $5.65 billion
** As of last close, TMO has fallen 16.4% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.